Chronic Pain in Patients with Spinal Muscular Atrophy in Switzerland: A Query to the Spinal Muscular Atrophy Registry
- PMID: 38792340
- PMCID: PMC11122245
- DOI: 10.3390/jcm13102798
Chronic Pain in Patients with Spinal Muscular Atrophy in Switzerland: A Query to the Spinal Muscular Atrophy Registry
Abstract
Background and Objectives: Chronic pain is a common symptom in various types of neuromuscular disorders. However, for patients with spinal muscular atrophy (SMA), the literature regarding chronic pain is scarce. Thus, this study assessed the prevalence of chronic pain in children, adolescents, and adults with SMA and investigated the influence of clinical characteristics on chronic pain. Materials and Methods: This study used data from 141 patients, which were collected by the Swiss Registry for Neuromuscular Disorders. Extracted data included information on pain (present yes/no, pain location, and pain medication) and clinical characteristics, such as SMA type, motor function, wheelchair use, scoliosis, and contractures. Results: The analyses revealed that the highest prevalence of chronic pain was observed in adolescents with 62%, followed by adults with 48%, children (6-12 years) with 39%, and children < 6 years with 10%. The legs, back, and hips were most frequently reported as pain locations. Sex (females), age (adolescents), and the presence of contractures and scoliosis (with surgery) were factors that were associated with chronic pain. Conclusions: These findings contribute to a better understanding of pain in SMA, shedding light on its prevalence and characteristics in different age groups, which underscores the importance of assessing and managing pain in patients with SMA.
Keywords: Swiss-Reg-NMD; chronic pain; patient-reported outcome measure; spinal muscular atrophy.
Conflict of interest statement
The authors declare no conflicts of interest for this manuscript.
Figures


Similar articles
-
RegistrAME: the Spanish self-reported patient registry of spinal muscular atrophy.Orphanet J Rare Dis. 2024 Feb 19;19(1):76. doi: 10.1186/s13023-024-03071-7. Orphanet J Rare Dis. 2024. PMID: 38373977 Free PMC article.
-
Systematic Literature Review of the Natural History of Spinal Muscular Atrophy: Motor Function, Scoliosis, and Contractures.Neurology. 2023 Nov 21;101(21):e2103-e2113. doi: 10.1212/WNL.0000000000207878. Epub 2023 Oct 9. Neurology. 2023. PMID: 37813581 Free PMC article.
-
Treatment of spinal muscular atrophy with Onasemnogene Abeparvovec in Switzerland: a prospective observational case series study.BMC Neurol. 2023 Feb 28;23(1):88. doi: 10.1186/s12883-023-03133-6. BMC Neurol. 2023. PMID: 36855136 Free PMC article.
-
Pain in Children and Adolescents with Spinal Muscular Atrophy: A Longitudinal Study from a Patient Registry.Children (Basel). 2023 Nov 30;10(12):1880. doi: 10.3390/children10121880. Children (Basel). 2023. PMID: 38136082 Free PMC article.
-
Drug treatment for spinal muscular atrophy type I.Cochrane Database Syst Rev. 2019 Dec 11;12(12):CD006281. doi: 10.1002/14651858.CD006281.pub5. Cochrane Database Syst Rev. 2019. PMID: 31825542 Free PMC article.
References
-
- Bushby K., Finkel R., Birnkrant D.J., Case L.E., Clemens P.R., Cripe L., Kaul A., Kinnett K., McDonald C., Pandya S., et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: Implementation of multidisciplinary care. Lancet Neurol. 2010;9:177–189. doi: 10.1016/s1474-4422(09)70272-8. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources